YOLK SAC TUMOR
Clinical trials for YOLK SAC TUMOR explained in plain language.
Never miss a new study
Get alerted when new YOLK SAC TUMOR trials appear
Sign up with your email to follow new studies for YOLK SAC TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells target tough childhood cancers
Disease control OngoingThis early-phase study is testing a new type of cell therapy called AGAR T cells in children and young adults with solid tumors that have come back or haven't responded to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and…
Matched conditions: YOLK SAC TUMOR
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test supercharged immune cells to attack tough cancers
Disease control OngoingThis early-stage study is testing a new type of treatment called CATCH T cells in adults with advanced solid tumors that have a specific marker (GPC3). Doctors take a patient's own immune cells, genetically modify them in a lab to better recognize and attack cancer, and then infu…
Matched conditions: YOLK SAC TUMOR
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC